NEW YORK (GenomeWeb) – German genetic testing firm CeGaT has been gearing up to venture further into international markets, including the US.

Over the last half year or so, the Tübingen-based company has optimized its workflows for diagnostic panels and exomes, allowing it to reduce turnaround times and prices. It also brought in new sequencing instrumentation to increase its testing capacity and recently passed an inspection for CAP accreditation of its laboratory.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.